Inactief instrument

Andere talen Ekso Bionics Holdings Inc Deutsche Boerse AG

Aandelen

US2826441030

slotkoers Deutsche Boerse AG Andere beurzen
- ^EUR	-

25/06	Ekso Bionics kondigt onderzoekssamenwerking met Shepherd Center aan	CI
17/06	Ekso Bionics Holdings, Inc. Benoemt Deborah Lafer Scher tot lid van de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Ekso Bionics Announces Research Partnership with Shepherd Center	25/06
Ekso Bionics Announces Research Partnership with Shepherd Center	25/06
Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors	17/06
Ekso Bionics Holdings, Inc. Appoints Deborah Lafer Scher to its Board of Directors	17/06
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky	10/05
Ekso Bionics: Q1 Earnings Snapshot	29/04
Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Posts Q1 Revenue $3.8M, vs. Street Est of $5M	29/04
Ekso Bionics Announces First Quarter 2024 Financial Results	29/04
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024	22/04
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal	12/04
Certain Warrants of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	17/03
Certain Common Stock of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	17/03
Ekso Bionics: Q4 Earnings Snapshot	04/03
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04/03
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	04/03
Ekso Bionics Reports Record Annual Revenue of $18.3 Million	04/03
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024	26/02
Ekso Bionics Announces $4.6 Million Registered Direct Offering	11/01
Ekso Bionics Launches GaitCoach Software for EksoNR	08/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ekso Bionics Holdings Inc Deutsche Boerse AG

Aandelen

US2826441030

Andere talen

Filters